Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients with Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem Cell Transplantation

Tso Fu Wang, He Huang, Cheng Hwai Tzeng, Po Nan Wang, Tong Wu, Jing Sun, Jih Luh Tang, Jiong Hu, Sheng Fung Lin, Ruey Ho Kao

研究成果: 雜誌貢獻文章

6 引文 (Scopus)

摘要

We retrospectively analyzed the impact of donor characteristics and HLA matching on outcomes in Chinese patients undergoing unrelated hematopoietic stem cell transplantation (HSCT). A total of 693 patients with hematologic malignancies who underwent HSCT between 2005 and 2010 had available survival data at 100 days or 1 year posttransplantation in the Buddhist Tzu-Chi Stem Cell Center database. The overall survival rates at 100 days and 1 year were 83.3% and 65.2%, respectively. Mismatches of HLA-A, -B, and -DRB1 at the antigen or allele level, along with inadequate cell dose, were associated with a significant risk of mortality (hazard ratio [HR] = 2.36, P < .001; HR = 1.44, P = .005; and HR = 2.20, P = .009, respectively). In 107 donors with matched HLA-A, -B and -DRB1 and known HLA-C match status, 22.4% had an HLA-C antigen mismatch, resulting in an HR of 2.87 for mortality relative to complete 8/8 matches (P = .005). Recipients with unknown HLA-C match status also had a significantly worse outcome (HR = 1.73; P = .039). Multivariate analysis revealed that cell dose and HLA-A, -B, -C, and -DRB1 antigen match status significantly affected the final outcome of survival (P = .012 and <.001, respectively). Our data indicate that HLA-C match status should be confirmed before HSCT from an unrelated donor. Inadequate cell dose remains an important determinant of poor transplantation survival. Further studies to elucidate the importance of matching of specific HLA loci are needed to better understand the risk of HSCT and improve patient outcomes.
原文英語
頁(從 - 到)1939-1944
頁數6
期刊Biology of Blood and Marrow Transplantation
18
發行號12
DOIs
出版狀態已發佈 - 十二月 1 2012
對外發佈Yes

指紋

HLA-C Antigens
Hematopoietic Stem Cell Transplantation
Hematologic Neoplasms
HLA-A Antigens
HLA-B Antigens
Tissue Donors
Survival
Antigens
Unrelated Donors
Mortality
Stem Cells
Multivariate Analysis
Survival Rate
Transplantation
Alleles
Databases

ASJC Scopus subject areas

  • Hematology
  • Transplantation

引用此文

Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients with Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem Cell Transplantation. / Wang, Tso Fu; Huang, He; Tzeng, Cheng Hwai; Wang, Po Nan; Wu, Tong; Sun, Jing; Tang, Jih Luh; Hu, Jiong; Lin, Sheng Fung; Kao, Ruey Ho.

於: Biology of Blood and Marrow Transplantation, 卷 18, 編號 12, 01.12.2012, p. 1939-1944.

研究成果: 雜誌貢獻文章

Wang, Tso Fu ; Huang, He ; Tzeng, Cheng Hwai ; Wang, Po Nan ; Wu, Tong ; Sun, Jing ; Tang, Jih Luh ; Hu, Jiong ; Lin, Sheng Fung ; Kao, Ruey Ho. / Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients with Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem Cell Transplantation. 於: Biology of Blood and Marrow Transplantation. 2012 ; 卷 18, 編號 12. 頁 1939-1944.
@article{3fbc4de8710e44ab9ae8da8af912fec3,
title = "Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients with Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem Cell Transplantation",
abstract = "We retrospectively analyzed the impact of donor characteristics and HLA matching on outcomes in Chinese patients undergoing unrelated hematopoietic stem cell transplantation (HSCT). A total of 693 patients with hematologic malignancies who underwent HSCT between 2005 and 2010 had available survival data at 100 days or 1 year posttransplantation in the Buddhist Tzu-Chi Stem Cell Center database. The overall survival rates at 100 days and 1 year were 83.3{\%} and 65.2{\%}, respectively. Mismatches of HLA-A, -B, and -DRB1 at the antigen or allele level, along with inadequate cell dose, were associated with a significant risk of mortality (hazard ratio [HR] = 2.36, P < .001; HR = 1.44, P = .005; and HR = 2.20, P = .009, respectively). In 107 donors with matched HLA-A, -B and -DRB1 and known HLA-C match status, 22.4{\%} had an HLA-C antigen mismatch, resulting in an HR of 2.87 for mortality relative to complete 8/8 matches (P = .005). Recipients with unknown HLA-C match status also had a significantly worse outcome (HR = 1.73; P = .039). Multivariate analysis revealed that cell dose and HLA-A, -B, -C, and -DRB1 antigen match status significantly affected the final outcome of survival (P = .012 and <.001, respectively). Our data indicate that HLA-C match status should be confirmed before HSCT from an unrelated donor. Inadequate cell dose remains an important determinant of poor transplantation survival. Further studies to elucidate the importance of matching of specific HLA loci are needed to better understand the risk of HSCT and improve patient outcomes.",
keywords = "Bone marrow, HLA-C antigen, Peripheral blood stem cell, Stem cell dose, Unrelated donor",
author = "Wang, {Tso Fu} and He Huang and Tzeng, {Cheng Hwai} and Wang, {Po Nan} and Tong Wu and Jing Sun and Tang, {Jih Luh} and Jiong Hu and Lin, {Sheng Fung} and Kao, {Ruey Ho}",
year = "2012",
month = "12",
day = "1",
doi = "10.1016/j.bbmt.2012.07.015",
language = "English",
volume = "18",
pages = "1939--1944",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Impact of Donor Characteristics and HLA Matching on Survival of Chinese Patients with Hematologic Malignancies Undergoing Unrelated Hematopoietic Stem Cell Transplantation

AU - Wang, Tso Fu

AU - Huang, He

AU - Tzeng, Cheng Hwai

AU - Wang, Po Nan

AU - Wu, Tong

AU - Sun, Jing

AU - Tang, Jih Luh

AU - Hu, Jiong

AU - Lin, Sheng Fung

AU - Kao, Ruey Ho

PY - 2012/12/1

Y1 - 2012/12/1

N2 - We retrospectively analyzed the impact of donor characteristics and HLA matching on outcomes in Chinese patients undergoing unrelated hematopoietic stem cell transplantation (HSCT). A total of 693 patients with hematologic malignancies who underwent HSCT between 2005 and 2010 had available survival data at 100 days or 1 year posttransplantation in the Buddhist Tzu-Chi Stem Cell Center database. The overall survival rates at 100 days and 1 year were 83.3% and 65.2%, respectively. Mismatches of HLA-A, -B, and -DRB1 at the antigen or allele level, along with inadequate cell dose, were associated with a significant risk of mortality (hazard ratio [HR] = 2.36, P < .001; HR = 1.44, P = .005; and HR = 2.20, P = .009, respectively). In 107 donors with matched HLA-A, -B and -DRB1 and known HLA-C match status, 22.4% had an HLA-C antigen mismatch, resulting in an HR of 2.87 for mortality relative to complete 8/8 matches (P = .005). Recipients with unknown HLA-C match status also had a significantly worse outcome (HR = 1.73; P = .039). Multivariate analysis revealed that cell dose and HLA-A, -B, -C, and -DRB1 antigen match status significantly affected the final outcome of survival (P = .012 and <.001, respectively). Our data indicate that HLA-C match status should be confirmed before HSCT from an unrelated donor. Inadequate cell dose remains an important determinant of poor transplantation survival. Further studies to elucidate the importance of matching of specific HLA loci are needed to better understand the risk of HSCT and improve patient outcomes.

AB - We retrospectively analyzed the impact of donor characteristics and HLA matching on outcomes in Chinese patients undergoing unrelated hematopoietic stem cell transplantation (HSCT). A total of 693 patients with hematologic malignancies who underwent HSCT between 2005 and 2010 had available survival data at 100 days or 1 year posttransplantation in the Buddhist Tzu-Chi Stem Cell Center database. The overall survival rates at 100 days and 1 year were 83.3% and 65.2%, respectively. Mismatches of HLA-A, -B, and -DRB1 at the antigen or allele level, along with inadequate cell dose, were associated with a significant risk of mortality (hazard ratio [HR] = 2.36, P < .001; HR = 1.44, P = .005; and HR = 2.20, P = .009, respectively). In 107 donors with matched HLA-A, -B and -DRB1 and known HLA-C match status, 22.4% had an HLA-C antigen mismatch, resulting in an HR of 2.87 for mortality relative to complete 8/8 matches (P = .005). Recipients with unknown HLA-C match status also had a significantly worse outcome (HR = 1.73; P = .039). Multivariate analysis revealed that cell dose and HLA-A, -B, -C, and -DRB1 antigen match status significantly affected the final outcome of survival (P = .012 and <.001, respectively). Our data indicate that HLA-C match status should be confirmed before HSCT from an unrelated donor. Inadequate cell dose remains an important determinant of poor transplantation survival. Further studies to elucidate the importance of matching of specific HLA loci are needed to better understand the risk of HSCT and improve patient outcomes.

KW - Bone marrow

KW - HLA-C antigen

KW - Peripheral blood stem cell

KW - Stem cell dose

KW - Unrelated donor

UR - http://www.scopus.com/inward/record.url?scp=84869080710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869080710&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2012.07.015

DO - 10.1016/j.bbmt.2012.07.015

M3 - Article

VL - 18

SP - 1939

EP - 1944

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 12

ER -